Exopharm Limited has signed a Master Collaborative Services Agreement (MSA) with the Astellas Institute for Regenerative Medicine (AIRM).
Also Read: Novavax and Israel Announce Advance...
Cergentis, a leading provider of genetic quality control solutions based on its proprietary Targeted Locus Amplification (TLA) technology platform, announced it has received internationally...
Denovo Biopharma LLC ("Denovo"), a pioneer in applying precision medicine to the development of innovative therapies, announced that the FDA has authorized the company's...
The Illinois Biotechnology Innovation Organization (iBIO), dedicated to inspiring the next generation of innovators and helping restore America's leadership in technology education, announced they...
Leica Biosystems, a cancer diagnostics company, has entered into an agreement with Leap Therapeutics, a biotechnology company, to develop a companion diagnostic to detect...
